Significant Changes to Guidelines for Alzheimer's Disease

The new criteria for Alzheimer’s disease suggest three unique phases, namely the preclinical, mild cognitive impairment (MCI), and dementia.

What’s vital about this multi-step staging system can’t be overemphasized. As a matter of fact, it’s the first moment when a specific staging system for this condition tried to integrate clinical symptoms along with the signal of brain alterations through biomarkers. Likewise, the suggested staging derived from the mounting proof of biomarker data, which recommended that the disease starts prior to the development of the symptoms. Not only that, the emerging technology can determine brain changes that pave the way for the development of symptoms.